CHICAGO, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international
pharmaceutical company, announced that it has added Tom Kolefas to its Advisory Board. Kolefas brings more than 25 years of Wall
Street experience on the buyside - managing both mutual fund and institutional equities at TIAA Investments, Jennison Associates,
Loomis Sayles, Mackay-Shields and Bank of New York; as well as industry experience as a chemical engineer and corporate development
officer at Engelhard/BASF. The Company looks forward to benefiting from his experience in the capital markets, his expertise on
what investors in different sectors and investment strategies look for, and his outstanding relationships in the investment
management space.
“Tom Kolefas brings a wealth of expertise to our company,” said Grigorios Siokas, Chief Executive Officer of Cosmos Holdings.
“He has a track record for success in identifying value within the mid-cap space. We look forward to his contribution as we
position ourselves for continued growth.”
"I am excited to be advising the team at Cosmos Holdings under the dynamic leadership of Gregory Siokas as it grows as a
company,” said Tom Kolefas. “Cosmos has a well-thought out, balanced strategy of organic growth, market share gains, new
product introductions and acquisitions to capitalize on the growth in the drug, nutraceutical, vitamin and Europe-only cannabis
end-markets in Europe, the U.S. and ultimately, the rest of the world."
About Cosmos Holdings, Inc.
Cosmos Holdings Inc. is an international pharmaceutical company focused on identifying, acquiring, developing, and
commercializing medicines to improve patients' lives and outcomes. Cosmos Holdings has offices and distribution centers in
Thessaloniki, Greece & in Harlow, UK. More information is available at www.cosmosholdingsinc.com.
FORWARD LOOKING STATEMENTS
Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A
of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and
uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and
discussed herein. Important factors that might cause such differences are discussed in the Company's filings with the Securities
and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated
in these forward-looking statements, if new information becomes available in the future.
Investor Relations Contact
Steve Carr
312-780-7211 / scarr@dresnerco.com
